DNA origami unfolding for drug delivery

One of the most fascinating branches of nanotechnology involves the sculpting of DNA into tiny shapes in a process known as DNA origami. The field was pioneered in 2006 by Paul Rothemund of Caltech. Now, researchers at Arizona State University's Biodesign Institute have taken Rothemund's work and given it more shape, adding contours that more accurately mimic shapes commonly found in nature. These shapes could house therapeutics and selectively deliver them on the molecular or cellular level. Release | Video

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.